Skip to Content

The randomized DYNAMIC Trial: ctDNA-guided approach towards adjuvant chemotherapy

Should we have a circulating tumor DNA (ctDNA)-guided approach towards adjuvant chemotherapy in patients with stage II colon cancer? Let Jeanne Tie, Medical Oncologist, update you on the area by the latest results from the randomized DYNAMIC trial.

Jeanne Tie

Få tilgang til artikkelen

Hvis du er lege, sykepleier eller annen helsepersonell, kan du få tilgang til hele artikkelen ved å opprette en profil på BestPractice Nordic.

Back to top